The use of fibrates and fenofibrates to reduce cholesterol levels has grown sharply in the United States over the past decade, despite mounting evidence that the drugs provide little benefit, ...
March 25, 2011 (Pomona, California) — The use of fibrates in the US has increased steadily over the past 10 years and remained consistent in Canada, with the market share dominated by brand-name ...
An extended follow-up to the ACCORD trial demonstrated no significant differences in CVD rate between statin-treated T2D patients randomized to concomitant fenofibrate and those randomized to masked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results